Mirati Therapeutics, Inc.
NasdaqGS:MRTX
$ 58.70
$0.00 (0.00%)
$ 58.70
$0.00 (0.00%)
End-of-day quote: 01/23/2024

MRTX - Mirati Therapeutics Stock Prediction 2025 - 2030

14 years of reliable Mirati Therapeutics stock forecast. The Wall Street analysts predict Data Unavailable for MRTX. See at a glance whether NasdaqGS:MRTX will rise in the future.

$0.00
Forecast 2023
$69.93 $77.75
Forecast 2025
$146.92
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
$0.00
Forecast 2025
$69.93 $77.75
Forecast 2030
$146.92
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
0
Price-to-book Ratio
4.35
Market Cap
4.12B
TEV
2.70 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$61.00

Mirati Therapeutics Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Mirati Therapeutics Stock Forecast 2023

$0.00

In the last five quarters, Mirati Therapeutics’s Price Target has risen from $61.00 to $61.00 - a 0% increase. Ten analysts predict that Mirati Therapeutics’s share price will fall in the coming year, reaching $0.00. This would represent a decrease of -100%.

-100%
-100
Last update: 05/12/2024

Highest Price Target $0.00

Average Price Target $0.00

Lowest Price Target $0.00

Mirati Therapeutics Stock Prediction 2025

Mirati Therapeutics Stock Predictions for Jan 2025.

In January 2025 analysts predict a stock price of $64.13. An increase of 9.24% compared to the previous month's estimate.

Mirati Therapeutics Stock Predictions for Feb 2025.

In February 2025 analysts predict a stock price of $65.36. An increase of 11.35% compared to the previous month's estimate.

Mirati Therapeutics Stock Predictions for Mar 2025.

In March 2025 analysts predict a stock price of $66.60. An increase of 13.46% compared to the previous month's estimate.

Mirati Therapeutics Stock Predictions for Apr 2025.

In April 2025 analysts predict a stock price of $67.84. An increase of 15.57% compared to the previous month's estimate.

Mirati Therapeutics Stock Predictions for May 2025.

In May 2025 analysts predict a stock price of $69.08. An increase of 17.68% compared to the previous month's estimate.

Mirati Therapeutics Stock Predictions for Jun 2025.

In June 2025 analysts predict a stock price of $70.32. An increase of 19.79% compared to the previous month's estimate.

Mirati Therapeutics Stock Predictions for Jul 2025.

In July 2025 analysts predict a stock price of $71.56. An increase of 21.9% compared to the previous month's estimate.

Mirati Therapeutics Stock Predictions for Aug 2025.

In August 2025 analysts predict a stock price of $72.80. An increase of 24.01% compared to the previous month's estimate.

Mirati Therapeutics Stock Predictions for Sep 2025.

In September 2025 analysts predict a stock price of $74.03. An increase of 26.12% compared to the previous month's estimate.

Mirati Therapeutics Stock Predictions for Oct 2025.

In October 2025 analysts predict a stock price of $75.27. An increase of 28.23% compared to the previous month's estimate.

Mirati Therapeutics Stock Predictions for Nov 2025.

In November 2025 analysts predict a stock price of $76.51. An increase of 30.34% compared to the previous month's estimate.

Mirati Therapeutics Stock Predictions for Dec 2025.

In December 2025 analysts predict a stock price of $77.75. An increase of 32.45% compared to the previous month's estimate.

Mirati Therapeutics Stock Forecast 2030

Stock Forecast for the Price of an Mirati Therapeutics Share in Jan 2030.

In January 2030, analysts believe the stock price will be $133.37. An increase of 127.21% compared to the previous month's estimate.

Stock Forecast for the Price of an Mirati Therapeutics Share in Feb 2030.

In February 2030, analysts believe the stock price will be $134.60. An increase of 129.31% compared to the previous month's estimate.

Stock Forecast for the Price of an Mirati Therapeutics Share in Mar 2030.

In March 2030, analysts believe the stock price will be $135.83. An increase of 131.4% compared to the previous month's estimate.

Stock Forecast for the Price of an Mirati Therapeutics Share in Apr 2030.

In April 2030, analysts believe the stock price will be $137.07. An increase of 133.5% compared to the previous month's estimate.

Stock Forecast for the Price of an Mirati Therapeutics Share in May 2030.

In May 2030, analysts believe the stock price will be $138.30. An increase of 135.6% compared to the previous month's estimate.

Stock Forecast for the Price of an Mirati Therapeutics Share in Jun 2030.

In June 2030, analysts believe the stock price will be $139.53. An increase of 137.7% compared to the previous month's estimate.

Stock Forecast for the Price of an Mirati Therapeutics Share in Jul 2030.

In July 2030, analysts believe the stock price will be $140.76. An increase of 139.8% compared to the previous month's estimate.

Stock Forecast for the Price of an Mirati Therapeutics Share in Aug 2030.

In August 2030, analysts believe the stock price will be $142.00. An increase of 141.9% compared to the previous month's estimate.

Stock Forecast for the Price of an Mirati Therapeutics Share in Sep 2030.

In September 2030, analysts believe the stock price will be $143.23. An increase of 144% compared to the previous month's estimate.

Stock Forecast for the Price of an Mirati Therapeutics Share in Oct 2030.

In October 2030, analysts believe the stock price will be $144.46. An increase of 146.1% compared to the previous month's estimate.

Stock Forecast for the Price of an Mirati Therapeutics Share in Nov 2030.

In November 2030, analysts believe the stock price will be $145.69. An increase of 148.2% compared to the previous month's estimate.

Stock Forecast for the Price of an Mirati Therapeutics Share in Dec 2030.

In December 2030, analysts believe the stock price will be $146.92. An increase of 150.3% compared to the previous month's estimate.

P/E
0.00
Beta
0
Price-to-book Ratio
4.35
Market Cap
4.12B
TEV
2.70 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$61.00

Mirati Therapeutics Analyst Ratings Frequently Asked Questions

Who are the analysts watching Mirati Therapeutics, Inc.?

The following analysts have recently covered Mirati Therapeutics:

Goldman Sachs
Marktfeld
Zacks Investment Research Inc.
Baptista Research
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Mirati Therapeutics, Inc.?

The following sell-side analysts have recently covered Mirati Therapeutics:

Richter, Salveen Jaswal
Paraskevopoulos, Michail
Zeng, Guoqian
Majumdar, Ishan
(This information refers to the last 90 days.)